{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:40:23Z","timestamp":1773337223073,"version":"3.50.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Malaria remains a significant global health challenge, with\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      causing the most severe cases and deaths, particularly in sub-Saharan Africa. An effective universal or pan vaccine is needed to augment current concerted control efforts. This\n                      <jats:italic>in silico<\/jats:italic>\n                      study investigated the global population coverage of human leukocyte antigen (HLA) that recognize experimentally validated CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell epitopes derived from three\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      antigens (CSP, AMA1 and TRAP), focusing on their potential for inclusion in a globally effective multi-epitope malaria vaccine.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>\n                      Sixteen experimentally validated CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell epitopes, together with the HLA typing data of study participants were curated from our previously published work. Using the Immune Epitope Database and Analysis conservancy and population coverage tool, the epitopes were analyzed for their conservancy and ability to bind HLA alleles from fourteen geographic subregions and seventy-eight countries.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      CSPep1, CSPep2, CSPep4, CSPep6, CSPep9, CSPep10, CSPep11, and TRAPep1 were 100% conserved across the sixteen strains of\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      while the other epitopes had conservancy of 55% or more. The CSP-derived epitope IQNSLSTEW (CSPep5) demonstrated the highest epitope coverage globally (&amp;gt;85%) and in West Africa (93.35%). In contrast, ILSVSSFLF (CSPep4) showed minimal coverage (&amp;lt;5% in Africa, &amp;lt;2% in other populations), and these highlight the impact of HLA diversity on epitope recognition. LLACAGLAYK (TRAPep1) and STEWSPCSV (CSPep10) had &amp;gt;50% population coverage but were highly conserved across diverse\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      strains. Spearman\u2019s correlation clustering shows three distinct clusters of epitopes with similar HLA coverage across the subregions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings highlight the importance of integrating host HLA binding promiscuity and parasite epitope conservation in developing universal or pan multi-epitope malaria vaccines. By combining conserved epitopes with broad HLA coverage, this approach promotes wide immune recognition while limiting strain-specific immune evasion. Incorporating relevant HLA class II and antibody epitopes could further enhance immune responses, providing effective protection for both children in malaria-endemic regions and malaria-na\u00efve travelers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fbinf.2026.1722563","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:48:29Z","timestamp":1773298109000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Population HLA coverage of experimentally characterized P. falciparum CD8+ T cell epitopes as potential components of a multi-epitope malaria vaccine construct: an in silico insight"],"prefix":"10.3389","volume":"6","author":[{"given":"Courage","family":"Siame","sequence":"first","affiliation":[{"name":"Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana","place":["Accra, Ghana"]}]},{"given":"Rafiatu","family":"Abdul-Mumin","sequence":"additional","affiliation":[{"name":"Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana","place":["Accra, Ghana"]}]},{"given":"Georgina","family":"Agyekum","sequence":"additional","affiliation":[{"name":"Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana","place":["Accra, Ghana"]}]},{"given":"Linda","family":"Akuffo","sequence":"additional","affiliation":[{"name":"Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana","place":["Accra, Ghana"]}]},{"given":"Ernest","family":"Afari","sequence":"additional","affiliation":[{"name":"Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana","place":["Accra, Ghana"]}]},{"given":"Cecilia Adwoa Biaa","family":"Yankey","sequence":"additional","affiliation":[{"name":"Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana","place":["Accra, Ghana"]}]},{"given":"Kwadwo Asamoah","family":"Kusi","sequence":"additional","affiliation":[{"name":"Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana","place":["Accra, Ghana"]}]}],"member":"1965","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.vaccine.2023.01.016","article-title":"Immunodominant T cell peptides from four candidate malarial antigens as biomarkers of protective immunity against malaria","volume":"41","author":"Belmonte","year":"2023","journal-title":"Vaccine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12936-025-05299-5","article-title":"Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ vaccine for the prevention of Plasmodium falciparum malaria infection","volume":"24","author":"Berry","year":"2025","journal-title":"Malar. J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1010409","DOI":"10.1371\/journal.ppat.1010409","article-title":"A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum","volume":"18","author":"Beutler","year":"2022","journal-title":"PLOS Pathog."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e42014","DOI":"10.1016\/j.heliyon.2025.e42014","article-title":"Computational design, expression, and characterization of a Plasmodium falciparum multi-epitope, multi-stage vaccine candidate (PfCTMAG)","volume":"11","author":"Chick","year":"2025","journal-title":"Heliyon"},{"key":"B5","doi-asserted-by":"publisher","first-page":"46621","DOI":"10.1038\/srep46621","article-title":"Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine","volume":"7","author":"Collins","year":"2017","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","article-title":"Malaria: biology and disease","volume":"167","author":"Cowman","year":"2016","journal-title":"Cell."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","article-title":"Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial","volume":"397","author":"Datoo","year":"2021","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S1473-3099(22)00442-X","article-title":"Efficacy and immunogenicity of R21\/Matrix-M vaccine against clinical malaria after 2 years\u2019 follow-up in children in Burkina Faso: a phase 1\/2b randomised controlled trial","volume":"22","author":"Datoo","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.1211548","article-title":"Live attenuated malaria vaccine designed to protect through hepatic CD8(+) T cell immunity","volume":"334","author":"Epstein","year":"2011","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e89154","DOI":"10.1172\/jci.insight.89154","article-title":"Protection against Plasmodium falciparum malaria by PfSPZ vaccine","volume":"2","author":"Epstein","year":"2017","journal-title":"JCI.Insight."},{"key":"B11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fimmu.2019.00397","article-title":"Comprehensive review of human plasmodium falciparum-specific CD8+ T cell epitopes","volume":"10","author":"Heide","year":"2019","journal-title":"Front. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"D13","DOI":"10.1016\/j.vaccine.2015.07.091","article-title":"The March toward malaria vaccines","volume":"33","author":"Hoffman","year":"2015","journal-title":"Vaccine, Adv. Vaccines Immun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nm.4110","article-title":"Protection against malaria at 1 year and immune correlates following PfSPZ vaccination","volume":"22","author":"Ishizuka","year":"2016","journal-title":"Nat. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4269\/ajtmh.20-0435","article-title":"Immunogenicity and protective efficacy of radiation-attenuated and chemo-attenuated PfSPZ vaccines in equatoguinean adults","volume":"104","author":"Jongo","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/infdis\/jiaa144","article-title":"Multifunctional antibodies are induced by the RTS,S malaria vaccine and associated with protection in a phase 1\/2a trial","volume":"224","author":"Kurtovic","year":"2020","journal-title":"J. Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"100898","DOI":"10.1016\/S2666-5247(24)00130-7","article-title":"Antibody mechanisms of protection against malaria in RTS,S-Vaccinated children: a post-hoc serological analysis of phase 2 trial","volume":"5","author":"Kurtovic","year":"2024","journal-title":"Lancet Microbe"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e8110","DOI":"10.1371\/journal.pone.0008110","article-title":"Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity","volume":"4","author":"Kusi","year":"2009","journal-title":"PLoS ONE"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0228177","DOI":"10.1371\/journal.pone.0228177","article-title":"Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population","volume":"15","author":"Kusi","year":"2020","journal-title":"PLOS ONE"},{"key":"B19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.vaccine.2021.12.042","article-title":"Towards large-scale identification of HLA-Restricted T cell epitopes from four vaccine candidate antigens in a malaria endemic community in Ghana","volume":"40","author":"Kusi","year":"2022","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS,S\/AS01 vaccine (MosquirixTM): an overview","volume":"16","author":"Laurens","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/j.1462-5822.2006.00778.x","article-title":"Getting infectious: formation and maturation of plasmodium sporozoites in the Anopheles vector","volume":"8","author":"Matuschewski","year":"2006","journal-title":"Cell. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic diversity and protective efficacy of the RTS,S\/AS01 malaria vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S1473-3099(24)00010-0","article-title":"R21\/Matrix-M malaria vaccine: a vital tool in the arsenal against malaria, not a silver bullet","volume":"24","author":"Ngou","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1797","DOI":"10.1002\/hsr2.1797","article-title":"Unlocking the potential of novel RTS, S\/AS01, and R21\/Matrix\u2010MTM malaria vaccines in African nations","volume":"7","author":"Oduoye","year":"2024","journal-title":"Health Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/infdis\/jis709","article-title":"Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications","volume":"207","author":"Ouattara","year":"2013","journal-title":"J. Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1004515","DOI":"10.1371\/journal.pmed.1004515","article-title":"Roll out and prospects of the malaria vaccine R21\/Matrix-M","volume":"22","author":"Seidlein","year":"2025","journal-title":"PLOS Med."},{"key":"B27","volume-title":"HLA coverage analysis of CD8+ epitopes additional files and scripts","author":"Siame","year":"2025"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-9-1","article-title":"HLA class I supertypes: a revised and updated classification","volume":"9","author":"Sidney","year":"2008","journal-title":"Bmc. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"9490","DOI":"10.1074\/jbc.M311331200","article-title":"A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites","volume":"279","author":"Silvie","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2552783","DOI":"10.1080\/22221751.2025.2552783","article-title":"Conserved multiepitopes in Plasmodium falciparum STEVORs enable rational design of a fusion antigen vaccine construct with broad immunogenicity","volume":"14","author":"Sun","year":"2025","journal-title":"Emerg. Microbes Infect."},{"key":"B31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40794-024-00222-3","article-title":"A landscape review of malaria vaccine candidates in the pipeline","volume":"10","author":"Tajudeen","year":"2024","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"B32","volume-title":"World malaria report","year":"2025"},{"key":"B33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12936-024-04903-4","article-title":"Malaria transmission heterogeneity in different eco-epidemiological areas of Western Kenya: a region-wide observational and risk classification study for adaptive intervention planning","volume":"23","author":"Zhou","year":"2024","journal-title":"Malar. J."}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2026.1722563\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:48:31Z","timestamp":1773298111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2026.1722563\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":33,"alternative-id":["10.3389\/fbinf.2026.1722563"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2026.1722563","relation":{},"ISSN":["2673-7647"],"issn-type":[{"value":"2673-7647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"article-number":"1722563"}}